Anagnostics Pursues CE-IVD Mark for Pathogen Array; Developing Next-gen Compact Sequencing | GenomeWeb

NEW YORK (GenomeWeb) – Austrian molecular diagnostics firm Anagnostics recently launched a new assay designed to detect sepsis-associated bacteria and fungi using a single array.

The company is also considering creating other arrays containing multiple test panels, though their future is linked to the creation of a new compact sequencing application the firm has in development.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.